RPL31P41

Across TCGA pan-cancer cohorts, RPL31P41 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RPL31P41 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RPL31P41 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL31P41 expression acts as an unfavorable survival marker.

KIRP, LUSC, and SKCM are the cancer types where RPL31P41 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.599	0.875	<.001	81	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
SKCM	DFS	Tertile	IV	0.064	0.497	.008	18	view →
PAAD	OS	Tertile	II,III,IV	0.188	0.508	.047	9	view →
THYM	DFS	Tertile	III,IV	0.205	0.774	.007	9	view →
READ	DFS	Tertile	IV	0.272	0.657	.010	9	view →
UCEC	DFS	Tertile	All	0.304	0.692	.046	6	view →
STAD	OS	Tertile	IV	0.229	0.533	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RPL31P41–KIRP (DFS)

Open the KIRP breakdown →